Company Profile

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE333.556.2 (+1.89 % )
PREV CLOSE (Rs.) 327.35
OPEN PRICE (Rs.) 337.40
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 269377
TODAY'S LOW / HIGH (Rs.)330.60 342.00
52 WK LOW / HIGH (Rs.)211.3 345
NSE333.75 6.35 (+1.94 % )
PREV CLOSE(Rs.) 327.40
OPEN PRICE (Rs.) 334.00
BID PRICE (QTY) 333.75 (781 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 6297479
TODAY'S LOW / HIGH(Rs.) 330.30 342.95
52 WK LOW / HIGH (Rs.)211.05 345

Board Meetings

Source Date Board Meeting Date Details
03-Jan-2020 23-Jan-2020 Quarterly Results
03-Oct-2019 23-Oct-2019 BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2019 ,inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2019 amongst other routine matters. The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from October 1, 2019 to October 25, 2019 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.
04-Jul-2019 25-Jul-2019 Quarterly Results
22-Apr-2019 25-Apr-2019 Bonus issue & Dividend
11-Apr-2019 25-Apr-2019 BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2019 ,inter alia, to consider and approve and take on record, the audited financial results (both standalone and consolidated) of the Company for the year ended March 31, 2019 amongst other routine matters.
09-Jan-2019 24-Jan-2019 BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2019 ,inter alia, to consider and approve This is to intimate that the date of next Board Meeting of Biocon Limited is scheduled on Thursday, January 24, 2019.
08-Oct-2018 25-Oct-2018 BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2018 ,inter alia, to consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the quarter and half year ended September 30, 2018 amongst other routine matters.
05-Jul-2018 26-Jul-2018 To intimate that the date of next Board Meeting of Biocon Limited is scheduled on Thursday,July 26,2018.
05-Apr-2018 26-Apr-2018 Final Dividend
22-Dec-2017 24-Jan-2018 This is to intimate the date of next Board Meeting of BIOCON LIMITED which is scheduled on Wednesday, January 24, 2018. Company : BIOCON LIMITED Symbol /Scrip Code : BIOCON / 532523 Board Meeting date : January 24, 2018 (Wednesday) Purpose : Inter alia, consider, approve and take on record, the un-audited financial results (both standalone and consolidated) of the Company for the quarter ended December 31, 2017 amongst other routine matters. In view of the above Board Meeting scheduled on January 24, 2018, the trading window for dealing in the Company's equity shares by the Company's designated persons and their immediate relatives will be closed from January 01, 2018 to January 26, 2018 (both days inclusive) in compliance with the provisions of the Company's Code of Conduct for prevention of Insider Trading, read with SEBI (Prohibition of Insider Trading) Regulations, 2015.